WeVote
Log In

Bill

Bill

SF 3179

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) program establishment; ME/CFS grant establishment; appropriating money

2025-2026 Regular Session Introduced by Liz Boldon and 3 co-sponsors

Minnesota bill establishes dedicated ME/CFS program and grant funding to support research, patient services, and healthcare for the chronic illness affecting thousands of state residents.

Author added Mann
#healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · SF 3179

Legislative bill overview

SF 3179 establishes a state program dedicated to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and creates grant funding mechanisms to support research, patient services, or healthcare initiatives related to the condition. The bill includes appropriations—meaning it allocates state funds—though the specific dollar amounts and exact program structure aren't detailed in the available summary information.

Why is this important

ME/CFS is a serious, often-disabling illness affecting an estimated 1-2.6 million Americans, yet it remains significantly underfunded in research relative to its prevalence and disease burden. A dedicated state program could improve diagnosis, treatment access, and quality of life for Minnesota residents while potentially advancing understanding of this poorly understood condition. State-level action may also signal federal policymakers to increase national research and healthcare support.

Potential points of contention

  • Funding prioritization: During budget constraints, allocating state resources to ME/CFS versus other health conditions may face opposition from those prioritizing different public health needs
  • Program scope uncertainty: The bill's effectiveness depends on implementation details—whether grants support research, clinical care, patient support services, or awareness campaigns remains unclear from current information
  • Evidence base and credibility: While ME/CFS is a recognized diagnosis, some debate persists in medical communities about optimal treatment approaches, which could influence program design arguments

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.